Calumet Specialty Products Stock Current Liabilities
CLMT Stock | USD 20.73 0.65 3.04% |
Calumet Specialty Products fundamentals help investors to digest information that contributes to Calumet Specialty's financial success or failures. It also enables traders to predict the movement of Calumet Stock. The fundamental analysis module provides a way to measure Calumet Specialty's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Calumet Specialty stock.
Total Current Liabilities is likely to gain to about 1.2 B in 2024, whereas Non Current Liabilities Total is likely to drop slightly above 1.2 B in 2024. Calumet | Current Liabilities |
Calumet Specialty Products Company Current Liabilities Analysis
Calumet Specialty's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Calumet Specialty Current Liabilities | 626.6 M |
Most of Calumet Specialty's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Calumet Specialty Products is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Calumet Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Calumet Specialty is extremely important. It helps to project a fair market value of Calumet Stock properly, considering its historical fundamentals such as Current Liabilities. Since Calumet Specialty's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Calumet Specialty's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Calumet Specialty's interrelated accounts and indicators.
Click cells to compare fundamentals
Calumet Current Liabilities Historical Pattern
Today, most investors in Calumet Specialty Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Calumet Specialty's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Calumet Specialty current liabilities as a starting point in their analysis.
Calumet Specialty Current Liabilities |
Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
Calumet Liabilities And Stockholders Equity
Liabilities And Stockholders Equity |
|
In accordance with the recently published financial statements, Calumet Specialty Products has a Current Liabilities of 626.6 M. This is 91.55% lower than that of the Oil, Gas & Consumable Fuels sector and 72.72% lower than that of the Energy industry. The current liabilities for all United States stocks is 92.07% higher than that of the company.
Calumet Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Calumet Specialty's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Calumet Specialty could also be used in its relative valuation, which is a method of valuing Calumet Specialty by comparing valuation metrics of similar companies.Calumet Specialty is currently under evaluation in current liabilities category among its peers.
Calumet Specialty Current Valuation Drivers
We derive many important indicators used in calculating different scores of Calumet Specialty from analyzing Calumet Specialty's financial statements. These drivers represent accounts that assess Calumet Specialty's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Calumet Specialty's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 285.5M | 245.3M | 1.0B | 1.3B | 1.4B | 1.1B | |
Enterprise Value | 1.6B | 1.5B | 2.6B | 3.0B | 3.6B | 1.9B |
Calumet Specialty ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Calumet Specialty's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Calumet Specialty's managers, analysts, and investors.Environmental | Governance | Social |
Calumet Fundamentals
Return On Equity | -11.72 | ||||
Return On Asset | 0.0167 | ||||
Profit Margin | (0.05) % | ||||
Operating Margin | (0.04) % | ||||
Current Valuation | 3.86 B | ||||
Shares Outstanding | 85.9 M | ||||
Shares Owned By Insiders | 21.24 % | ||||
Shares Owned By Institutions | 37.43 % | ||||
Number Of Shares Shorted | 5.37 M | ||||
Price To Earning | 286.67 X | ||||
Price To Book | 19.32 X | ||||
Price To Sales | 0.44 X | ||||
Revenue | 4.18 B | ||||
Gross Profit | 370.2 M | ||||
EBITDA | 418.2 M | ||||
Net Income | 47.1 M | ||||
Cash And Equivalents | 50.5 M | ||||
Cash Per Share | 0.64 X | ||||
Total Debt | 2.19 B | ||||
Current Ratio | 0.60 X | ||||
Book Value Per Share | (7.83) X | ||||
Cash Flow From Operations | (14.9 M) | ||||
Short Ratio | 7.59 X | ||||
Earnings Per Share | (2.82) X | ||||
Price To Earnings To Growth | 2.71 X | ||||
Target Price | 24.6 | ||||
Number Of Employees | 1.58 K | ||||
Beta | 1.91 | ||||
Market Capitalization | 1.84 B | ||||
Total Asset | 2.75 B | ||||
Retained Earnings | (421.9 M) | ||||
Working Capital | (318 M) | ||||
Current Asset | 609 M | ||||
Current Liabilities | 626.6 M | ||||
Net Asset | 2.75 B |
About Calumet Specialty Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Calumet Specialty Products's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calumet Specialty using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calumet Specialty Products based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.